Gurion R, Rozovski U, Itchaki G, Gafter-Gvili A, et al. Humoral serologic response to the BNT162b2 vaccine is abrogated in lymphoma patients within the first 12 months following treatment with anti-CD2O antibodies. Haematologica 2021 Jul 29. doi: 10.3324/haematol.2021.279216.
PMID: 34320790